Aligos Therapeutics (ALGS) Stock Chart & Stock Price History $14.50 -2.37 (-14.05%) Closing price 03/3/2025 04:00 PM EasternExtended Trading$14.48 -0.03 (-0.17%) As of 03/3/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Aligos Therapeutics Stock Price Performance 5 Day Performance-13.48%1 Month Performance-44.30%3 Month Performance-43.75%6 Month Performance+23.51%Year-To-Date Performance-63.60%1 Year Performance-41.42% Receive ALGS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aligos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address ALGS Stock Chart for Tuesday, March, 4, 2025 ALGS Chart by TradingView Aligos Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/03/2025$16.87$14.50-14.05%$17.25$14.17206,855 shs$52.03 million02/28/2025$16.76$16.87+0.66%$17.39$15.88134,098 shs$60.53 million02/27/2025$17.75$16.76-5.58%$18.61$16.60183,507 shs$60.14 million02/26/2025$17.33$17.75+2.42%$18.75$17.39268,671 shs$63.69 million02/25/2025$17.82$17.33-2.75%$17.89$16.02275,729 shs$62.18 million02/24/2025$18.63$17.82-4.35%$18.99$17.17291,612 shs$63.97 million02/21/2025$20.85$18.63-10.65%$21.88$18.13338,265 shs$66.84 million02/20/2025$22.28$20.85-6.42%$22.40$20.51138,995 shs$74.85 million02/19/2025$22.79$22.28-2.24%$23.13$21.61114,252 shs$79.99 million02/18/2025$23.67$22.79-3.72%$24.33$22.48130,243 shs$81.82 million Get the Latest News and Ratings for ALGS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aligos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 02/17/2025$23.67$23.67$23.73$20.54304,878 shs$84.98 million02/14/2025$21.01$23.67+12.66%$23.73$20.54304,878 shs$84.98 million02/13/2025$21.01$21.01$21.95$20.12261,783 shs$75.43 million02/12/2025$26.02$21.01-19.25%$26.38$20.16720,335 shs$75.43 million02/11/2025$27.70$26.02-6.06%$27.30$25.54150,376 shs$93.41 million02/10/2025$27.53$27.70+0.62%$29.54$27.44191,686 shs$99.44 million02/07/2025$27.50$27.53+0.11%$28.91$26.61247,099 shs$98.83 million02/06/2025$25.32$27.50+8.61%$28.10$25.02260,921 shs$98.73 million02/05/2025$26.03$25.32-2.73%$26.70$24.70225,904 shs$90.90 million02/04/2025$22.57$26.03+15.33%$26.15$22.90206,270 shs$93.45 million02/03/2025$25.80$22.57-12.52%$25.24$22.56200,958 shs$81.03 million Related Companies Y-mAbs Therapeutics Stock Chart Septerna Stock Chart COMPASS Pathways Stock Chart Bright Minds Biosciences Stock Chart Tango Therapeutics Stock Chart biote Stock Chart Canopy Growth Stock Chart Eledon Pharmaceuticals Stock Chart Alumis Stock Chart Benitec Biopharma Stock Chart Receive ALGS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aligos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ALGS) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredLeaked Trump video exposes his secret stocksTen investments secretly owned by Trump’s biggest backers. Ten investments intrinsically tied to the polici...Porter & Company | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aligos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aligos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
